Bejing beat us to it. - covid
Here, we present a post-market validation study of the Beijing Genomics institute (BGI) MGISP-960 robotic nucleic extraction instrument, together with either the SLAN 96S real-time PCR analyser, or Bioer LineGene 9600 PCR analyser, and using the MGIEasy Magnetic Beads Virus DNA/RNA Extraction Kit (Ref 1000021043), and BGI Real-time fluorescent RT-PCR kit for detecting 2019-nCoV (Ref MFG030010).
This equipment and reagents have been made available to selected Australian laboratories for diagnostic use
- Forums
- ASX - By Stock
- Beijing beat us to it
GTG
genetic technologies limited
Add to My Watchlist
0.00%
!
3.9¢

Bejing beat us to it. - covidHere, we present a post-market...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
3.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $52.08M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
GTG (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online